Skip to main content

High-Throughput Screening of Antibiotic-Resistant Bacteria with Picodroplets

case study icon

High-Throughput Screening of Antibiotic-Resistant Bacteria with Picodroplets

case study icon
SLAS 2024 Microscale Innovation in Life Sciences Symposium

Summary

This study demonstrates a novel use of microfluidic picodroplet technology to rapidly screen and isolate antibiotic-resistant bacteria. By capturing individual bacterial cells in picodroplets, researchers achieved high-throughput, label-free screening, allowing for the quick identification of antibiotic resistance. This method provides a powerful alternative to traditional screening and offers a potential path forward in combating multidrug-resistant bacteria like Staphylococcus aureus and E. coli. Learn how our technology is accelerating research to address global antibiotic resistance threats.

Research highlights

  • Study Title: High-throughput screening of antibiotic-resistant bacteria in picodroplets
  • Authors: Liu, X. et al.
  • Published In: Lab Chip, Issue 9, 2016 (pp 1636–1643)
  • DOI: 10.1098/rsif.2015.0216

Key findings

  • Efficient isolation of antibiotic-resistant strains
  • Label-free high-throughput screening with picodroplets
  • Proof-of-concept demonstrated with E. coli and fusidic acid resistance

The Next Generation: Cyto-Mine® Chroma

Automate. Accelerate. Analyze millions of cells in a single day.

Think Cyto-Mine®, but supercharged, enabling multiplexing and greater assay flexibility to fit your needs. It means that you can examine vastly greater numbers of cells — and isolate the most valuable ones— with unparalleled precision.

Cyto-Mine® Chroma
Contact sales